Isracann Biosciences Inc. (ISCNF)
Isracann Biosciences Inc. operates in the Drug Manufacturers - Specialty & Generic industry of the Healthcare sector, headquartered in Vancouver, BC, CA. The stock last traded at $0.00, up 0.00% on the session, giving a market capitalisation of $1,760. On trailing twelve-month figures it carries a trailing P/E of -0.47, a net margin of 0.0%. Its beta of 0.19 implies it has historically moved less than the broad market.
Founded in 2010 and based in Vancouver, Canada, Isracann Biosciences Inc. focuses on the cultivation and distribution of medical cannabis. The company conducts its operations and develops its growing infrastructure within Israel, also serving the German market through product exports. Its current name, Isracann Biosciences Inc., was adopted in October 2019, succeeding its former identity as Atlas Blockchain Group Inc.
Isracann Biosciences Inc. is most often compared with the following Healthcare names: